![]() | This article has multiple issues. Please help
improve it or discuss these issues on the
talk page. (
Learn how and when to remove these template messages)
|
Oncotherm medical devices are produced by Oncotherm Ltd. and used for cancer treatment.
The company's methodology is based on the view of its founder that the heat-dose sensitive characterization of tissue is at the core of the oncothermia treatment. [1] The tumor tissue has lower impedance than the surrounding tissues,[ citation needed] so most of the energy is transmitted and absorbed by the cancerous lesion. This selection of the tumor tissues (self-focusing) renders external focusing unnecessary. [2]
Oncotherm Ltd. was founded in 1988 by Prof. Dr. András Szász [3] in Hungary. In 2002, it received investment from a German company and was reorganized as a German-Hungarian company consisting of Oncotherm Hungary Ltd [4] and Oncotherm GmbH. [5]
Their main products are the Oncotherm EHY-2000 [6] and the Oncotherm EHY-2030, [7] hyperthermia devices using the thermoelectric effects of electrical fields.
More than 450 devices have been placed into operation, mostly in Germany and South Korea, and performed over 400,000 treatments. [8] The devices are not approved by the U.S. Food and Drug Administration.[ citation needed]
![]() | This article has multiple issues. Please help
improve it or discuss these issues on the
talk page. (
Learn how and when to remove these template messages)
|
Oncotherm medical devices are produced by Oncotherm Ltd. and used for cancer treatment.
The company's methodology is based on the view of its founder that the heat-dose sensitive characterization of tissue is at the core of the oncothermia treatment. [1] The tumor tissue has lower impedance than the surrounding tissues,[ citation needed] so most of the energy is transmitted and absorbed by the cancerous lesion. This selection of the tumor tissues (self-focusing) renders external focusing unnecessary. [2]
Oncotherm Ltd. was founded in 1988 by Prof. Dr. András Szász [3] in Hungary. In 2002, it received investment from a German company and was reorganized as a German-Hungarian company consisting of Oncotherm Hungary Ltd [4] and Oncotherm GmbH. [5]
Their main products are the Oncotherm EHY-2000 [6] and the Oncotherm EHY-2030, [7] hyperthermia devices using the thermoelectric effects of electrical fields.
More than 450 devices have been placed into operation, mostly in Germany and South Korea, and performed over 400,000 treatments. [8] The devices are not approved by the U.S. Food and Drug Administration.[ citation needed]